E1	Observation:T1 Name:T2 Eq-Comparison:E2 Eq-Comparison2:E3
E2	Eq-Comparison:T3 Value:T4 Unit:T5 Operator:T6
E3	Eq-Comparison:T7 Operator:T8 Value:T9 Unit:T10
E4	Observation:T11 Name:T12 Eq-Comparison:E5
E5	Eq-Comparison:T13 Operator:T14 Value:T15 Unit:T16 Per:T17
E6	Observation:T18 Name:T19
E7	Eq-Comparison:T20 Operator:T21 Value:T22 Unit:T23 Per:T24
E8	Observation:T25 Name:T26 Eq-Comparison:E9
E9	Eq-Comparison:T27 Operator:T28 Value:T29 Unit:T30
E10	Observation:T31 Name:T32 Eq-Comparison:E11
E11	Eq-Comparison:T33 Operator:T34 Value:T35 Temporal-Unit:T36
E12	And:T37 Arg:E8 Arg2:E10
E13	Assertion:T38 Asserted:E15
E14	Modifier:T39 Modifies:T41
E15	Condition:T40 Name:T41
E16	Condition:T42 Name:T43
E17	Condition:T44 Name:T45
E18	Or:T46 Arg:E16 Arg2:E17
E19	Modifier:T47 Modifies:T43
E20	Modifier:T48 Modifies:T43
E21	Or:T49 Arg:E20 Arg2:E19
E22	Or:T50 Arg:E15 Arg2:E16
E23	Eq-Comparison:T51 Temporal-Period:T52
E24	Condition:T53 Name:T54 Severity:T57 Temporality:E23
E25	Eq-Comparison:T55 Value:T56 Operator:T58 Value2:T57
E26	Condition:T59 Name:T60
E27	Condition:T61 Name:T62
E28	Condition:T63 Name:T64
E29	Condition:T65 Name:T66 Stability:T67 Temporality:E31
E30	Or:T68 Arg:E28 Arg2:E29
E31	Eq-Comparison:T69 Temporal-Period:T70 Value:T71 Temporal-Unit:T72
E32	Condition:T73 Name:T74 Severity:T75
E33	Condition:T76 Name:T77 Stage:E34
E34	Eq-Comparison:T78 Value:T79 Value2:T80 Unit:T81
E35	Condition:T82 Name:T83
E36	Drug:T84 Name:T85
E37	Drug:T87 Name:T86
E38	Or:T88 Arg:E36 Arg2:E37
E39	Eq-Comparison:T89 Temporal-Period:T90
E40	Condition:T91 Name:T92 Temporality:E39
E41	Procedure:T93
E42	Temporal-Connection:T94 Arg:E40 Arg2:E41
E43	Drug:T95 Name:T96
E44	Drug:T97 Name:T98
E45	Or:T99 Arg:E43 Arg2:E44
E46	Observation:T100 Name:T101 Eq-Comparison:E47
E47	Eq-Comparison:T102 Operator:T103 Value:T104 Unit:T105
E48	Observation:T106 Name:T107 Eq-Comparison:E49
E49	Eq-Comparison:T108 Operator:T109 Value:T110 Unit:T111 Per:T112
E50	Observation:T113 Name:T114
E51	Observation:T115 Name:T116
E52	Or:T117 Arg:E50 Arg2:E51
E53	Eq-Comparison:T118 Operator:T119 Value:T120 Unit:T121
E54	Observation:T122 Name:T123 Eq-Comparison:E55
E55	Eq-Comparison:T124 Operator:T125 Value:T126 Unit:T127 Per:T128
E56	Study:T129 Stability:T130
E57	Assertion:T131 Asserted:T130
E58	Condition:T132 Name:T133
E59	Or:T134 Arg:E54 Arg2:E58
T1	Observation 44 41	msSBP
T2	Observation-Name 44 41	msSBP
T3	Eq-Comparison 38 35	145 mmHg ≤
T4	Eq-Value 31 28	145
T5	Eq-Unit 36 33	mmHg
T6	Eq-Operator 38 35	≤
T7	Eq-Comparison 56 52	≤ 190 mmHg
T8	Eq-Operator 46 43	≤
T9	Eq-Value 51 47	190
T10	Eq-Unit 56 52	mmHg
T11	Observation 75 71	Triglycerides
T12	Observation-Name 75 71	Triglycerides
T13	Eq-Comparison 90 83	< 500 mg/dL
T14	Eq-Operator 77 73	<
T15	Eq-Value 82 77	500
T16	Eq-Unit 85 80	mg
T17	Eq-Unit 90 83	dL
T18	Observation 103 94	LDL-C
T19	Observation-Name 103 94	LDL-C
T20	Eq-Comparison 118 106	≤ 250 mg/dL
T21	Eq-Operator 105 96	≤
T22	Eq-Value 110 100	250
T23	Eq-Unit 113 103	mg
T24	Eq-Unit 118 106	dL
T25	Observation 150 136	sSBP
T26	Observation-Name 150 136	sSBP
T27	Eq-Comparison 161 145	≥ 20mmHg
T28	Eq-Operator 152 138	≥
T29	Eq-Value 156 141	20
T30	Eq-Unit 161 145	mmHg
T31	Observation 170 154	sDBP
T32	Observation-Name 170 154	sDBP
T33	Eq-Comparison 181 163	≥ 10mmHg
T34	Eq-Operator 172 156	≥
T35	Eq-Value 176 159	10
T36	Eq-Temporal-Unit 181 163	mmHg
T37	And 165 149	and
T38	Assertion 198 180	symptomatic
T39	Modifier 210 192	orthostatic
T40	Condition 222 204	hypotension
T41	Condition-Name 222 204	hypotension
T42	Condition 262 242	hypertension
T43	Condition-Name 262 242	hypertension
T44	Condition 279 259	dyslipidemia
T45	Condition-Name 279 259	dyslipidemia
T46	Or 266 246	and
T47	Modifier 249 229	iatrogenic
T48	Modifier 236 218	secondary
T49	Or 238 219	/
T50	Or 226 208	and
T51	Eq-Comparison 292 272	history
T52	Eq-Temporal-Period 292 272	history
T53	Condition 332 312	cerebral ischemia
T54	Condition-Name 332 312	cerebral ischemia
T55	Eq-Comparison 314 294	moderate to severe
T56	Severity 304 284	moderate
T57	Severity 314 294	severe
T58	Eq-Operator 307 287	to
T59	Condition 354 333	cerebral hemorrhage
T60	Condition-Name 354 333	cerebral hemorrhage
T61	Condition 382 360	transient ischemic attack
T62	Condition-Name 382 360	transient ischemic attack
T63	Condition 406 383	myocardial infarction
T64	Condition-Name 406 383	myocardial infarction
T65	Condition 427 403	angina
T66	Condition-Name 427 403	angina
T67	Stability 420 396	unstable
T68	Or 411 387	or
T69	Eq-Comparison 449 424	past 6 months
T70	Eq-Temporal-Period 439 415	past
T71	Eq-Value 442 417	6
T72	Eq-Temporal-Unit 449 424	months
T73	Condition 471 446	heart failure
T74	Condition-Name 471 446	heart failure
T75	Severity 457 432	severe
T76	Condition 500 474	New York Heart Association
T77	Condition-Name 500 474	New York Heart Association
T78	Eq-Comparison 528 502	class III and IV
T79	Eq-Value 521 495	III
T80	Eq-Value 528 502	IV
T81	Eq-Unit 517 491	class
T82	Condition 553 525	hypersensitivity
T83	Condition-Name 553 525	hypersensitivity
T84	Drug 568 540	telmisartan
T85	Drug-Name 568 540	telmisartan
T86	Drug-Name 584 556	rosuvastatin
T87	Drug 584 556	rosuvastatin
T88	Or 571 543	or
T89	Eq-Comparison 597 569	history
T90	Eq-Temporal-Period 597 569	history
T91	Condition 611 583	angioedema
T92	Condition-Name 611 583	angioedema
T93	Procedure 627 599	treatment
T94	Temporal-Connection 617 589	after
T95	Drug 675 645	angiotensin-converting enzyme inhibitors
T96	Drug-Name 675 645	angiotensin-converting enzyme inhibitors
T97	Drug 683 653	ARBs
T98	Drug-Name 683 653	ARBs
T99	Or 678 648	or
T100	Observation 709 679	creatinine phosphokinase
T101	Observation-Name 709 679	creatinine phosphokinase
T102	Eq-Comparison 753 721	≥3 times the upper limit of normal
T103	Eq-Operator 718 688	≥
T104	Eq-Value 721 689	3
T105	Eq-Unit 753 721	upper limit of normal
T106	Observation 795 763	estimated glomerular filtration rate
T107	Observation-Name 795 763	estimated glomerular filtration rate
T108	Eq-Comparison 810 774	≤30 mL/min
T109	Eq-Operator 797 765	≤
T110	Eq-Value 801 767	30
T111	Eq-Unit 804 770	mL
T112	Eq-Temporal-Unit 810 774	min
T113	Observation 838 802	aspartate aminotransferase
T114	Observation-Name 838 802	aspartate aminotransferase
T115	Observation 867 831	alanine aminotransferase
T116	Observation-Name 867 831	alanine aminotransferase
T117	Or 842 806	and
T118	Eq-Comparison 911 873	≥3 times the upper limit of normal
T119	Eq-Operator 876 840	≥
T120	Eq-Value 879 841	3
T121	Eq-Unit 911 873	upper limit of normal
T122	Observation 926 888	potassium
T123	Observation-Name 926 888	potassium
T124	Eq-Comparison 949 907	>5.5 mmol/L
T125	Eq-Operator 935 897	>
T126	Eq-Value 940 900	5.5
T127	Eq-Unit 945 905	mmol
T128	Eq-Unit 949 907	L
T129	Study 1009 967	study
T130	Stability 984 942	affect
T131	Assertion 977 935	could
T132	Condition 966 924	diseases
T133	Condition-Name 966 924	diseases
T134	Or 953 911	or
A1	Observation-Type-Value T2 vital
A2	Eq-Operator-Value T6 LTEQ
A3	Eq-Operator-Value T8 LTEQ
A4	Observation-Type-Value T12 lab
A5	Eq-Operator-Value T14 LT
A6	Observation-Type-Value T19 lab
A7	Eq-Operator-Value T21 LTEQ
A8	Observation-Type-Value T26 vital
A9	Eq-Operator-Value T28 GTEQ
A10	Observation-Type-Value T32 vital
A11	Eq-Operator-Value T34 GTEQ
A12	Assertion-Type-Value E13 possible
A13	Eq-Temporal-Period-Value T52 past
A14	Severity-Value T56 moderate
A15	Severity-Value T57 severe
A16	Eq-Operator-Value T58 BETWEEN
A17	Stability-Value T67 change
A18	Eq-Temporal-Period-Value T70 past
A19	Eq-Temporal-Unit-Value T72 month
A20	Severity-Value T75 severe
A21	Eq-Temporal-Period-Value T90 past
A22	Temporal-Connection-Type-Value E42 after
A23	Observation-Type-Value T101 lab
A24	Eq-Operator-Value T103 GTEQ
A25	Eq-Unit-Value T105 ref-range-normal
A26	Observation-Type-Value T107 lab
A27	Eq-Operator-Value T109 LTEQ
A28	Eq-Temporal-Unit-Value T112 minute
A29	Observation-Type-Value T114 lab
A30	Observation-Type-Value T116 lab
A31	Eq-Operator-Value T119 GTEQ
A32	Eq-Unit-Value T121 ref-range-normal
A33	Observation-Type-Value T123 lab
A34	Eq-Operator-Value T125 GT
A35	Stability-Value T130 change
A36	Assertion-Type-Value E57 hypothetical
R1	Equivalent-To Arg1:E33 Arg2:E32
R2	Caused-By Arg1:E35 Arg2:E36
R3	Caused-By Arg1:E35 Arg2:E37
R4	Using Arg1:E41 Arg2:E43
R5	Caused-By Arg1:T130 Arg2:E58